Can metformin prevent endothelial ischemia and reperfusion injury? The Metformin-FMD trial.

Trial Profile

Can metformin prevent endothelial ischemia and reperfusion injury? The Metformin-FMD trial.

Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Aug 2013

At a glance

  • Drugs Metformin (Primary) ; Caffeine
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Acronyms Metformin-FMD
  • Most Recent Events

    • 31 Aug 2013 Primary endpoint 'Flow-mediated-dilation' has not been met according to results presented at the 11th Congress of the European Association for Clinical Pharmacology and Therapeutics.
    • 31 Aug 2013 Results presented at the 11th Congress of the European Association for Clinical Pharmacology and Therapeutics.
    • 22 Feb 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top